1. PL3.2 Trabectedin for recurrent WHO grade II or III meningioma: a randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG). (6th September 2019) Authors: Preusser, M; Silvani, A; Le Rhun, E; Soffietti, R; Lombardi, G; Sepulveda, J; Brandal, P; Beaney, R; Bonneville-Levard, A; Lorgis, V; Bromberg, J; Erridge, S; Cameron, A; Marosi, C; Golfinopoulos, V; Gorlia, T; Weller, M; Wick, W Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗